IV Catheters, Needles, and Syringes Market to Reach USD 25 Billion by 2033 at a 6.5% CAGR - SRI

London, UK - October 2026 | Strategic Revenue Insights Inc. - The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disease, which require frequent medication administration, is driving demand for IV catheters, needles, and syringes. According to Strategic Revenue Insights, the global iv catheters, needles, and syringes market is projected to reach USD 25 billion by 2033, registering a CAGR of 6.5% from 2025 to 2033. The report was prepared by lead analyst Kamrul Hasan. The source report does not disclose detailed methodology, including the number of primary interviews or the specific secondary datasets used.

Key Takeaways

• Market value is projected to reach USD 25 billion by 2033, at a CAGR of 6.5% from 2025 to 2033.
• Products span peripheral, central venous, and midline catheters; hypodermic, insulin, spinal, and biopsy needles; and disposable, reusable, prefilled, and insulin syringes.
• The shift toward home healthcare and self-administration, and the growing use of disposable devices that reduce infection risk, are key trends.
• North America holds the largest share, followed by Europe and Asia Pacific, while Asia Pacific is expected to witness the highest growth rate.
• Named market participants include Becton, Dickinson and Company, B. Braun Melsungen AG, and Terumo Corporation.

Report URL: https://www.strategicrevenueinsights.com/industry/iv-catheters-needles-and-syringes-market

Chronic Disease Burden Drives Infusion Device Demand

Growth is significantly influenced by the rising prevalence of chronic diseases worldwide. Conditions such as diabetes, cancer, and cardiovascular disease require frequent administration of medications, which drives demand for these devices.

Technological advances are producing safer and more efficient products, and a growing geriatric population and rising healthcare expenditure in emerging economies are adding to demand. The shift toward home healthcare and self-administration is increasing the need for user-friendly devices.

Market Segmentation

By IV Catheters: Peripheral IV Catheters, Central Venous Catheters, and Midline Catheters.

By Needles: Hypodermic, Insulin, Spinal, and Biopsy Needles.

By Syringes: Disposable, Reusable, Prefilled, and Insulin Syringes. The source does not identify a largest segment.

Regional Outlook

The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds the largest market share, followed by Europe and the Asia Pacific region, while Asia Pacific is expected to witness the highest growth rate during the forecast period. The source provides no further region-specific market values or growth rates.

Competitive Landscape

The report names Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical, Medtronic plc, Cardinal Health, Inc., Nipro Corporation, Teleflex Incorporated, Vygon Group, Retractable Technologies, Inc., ICU Medical, Inc., and Fresenius Kabi AG as market participants.

Market Restraints

A stringent regulatory environment for device development and approval is a primary challenge, as complex requirements can be time-consuming and costly to meet.

Related Reports

https://www.strategicrevenueinsights.com/industry/drug-coated-balloons-market

https://www.strategicrevenueinsights.com/industry/brain-health-devices-market

https://www.strategicrevenueinsights.com/industry/capsule-endoscopy-diagnostics-market

https://www.strategicrevenueinsights.com/industry/wound-closure-surgical-products-market

https://www.strategicrevenueinsights.com/industry/ocular-surgery-devices-market

https://www.strategicrevenueinsights.com/industry/cardiac-poc-testing-devices-and-kits-market

https://www.strategicrevenueinsights.com/industry/wearable-injector-devices-market

https://www.strategicrevenueinsights.com/industry/extremity-reconstruction-devices-market

https://www.strategicrevenueinsights.com/industry/gastroenterology-devices-market

https://www.strategicrevenueinsights.com/industry/leadless-cardiac-pacemakers-market

Frequently Asked Questions

What will be the market size by 2033?

The market is projected to reach USD 25 billion by 2033.

What is the expected CAGR of the iv catheters, needles, and syringes market?

The market is projected to expand at a CAGR of 6.5% from 2025 to 2033.

Which segment is largest in the iv catheters, needles, and syringes market?

The source does not identify a largest product segment.

Which region leads the iv catheters, needles, and syringes market?

North America holds the largest market share, followed by Europe and the Asia Pacific region, while Asia Pacific is expected to witness the highest growth rate during the forecast period.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases